KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 77 filers reported holding KYMERA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,090,945 | -37.6% | 366,255 | +3.2% | 0.00% | -50.0% |
| Q2 2023 | $8,159,795 | -18.2% | 354,928 | +5.4% | 0.00% | 0.0% |
| Q1 2023 | $9,980,184 | +17.1% | 336,827 | -1.4% | 0.00% | 0.0% |
| Q4 2022 | $8,522,367 | +18.0% | 341,441 | +2.9% | 0.00% | 0.0% |
| Q3 2022 | $7,221,000 | +10.0% | 331,738 | -0.5% | 0.00% | +100.0% |
| Q2 2022 | $6,564,000 | -51.5% | 333,378 | +4.2% | 0.00% | -50.0% |
| Q1 2022 | $13,536,000 | -37.1% | 319,870 | -5.6% | 0.00% | -50.0% |
| Q4 2021 | $21,516,000 | +8.1% | 338,900 | +0.1% | 0.00% | 0.0% |
| Q3 2021 | $19,897,000 | +58.1% | 338,723 | +30.5% | 0.00% | +100.0% |
| Q2 2021 | $12,587,000 | +175.7% | 259,515 | +120.9% | 0.00% | +100.0% |
| Q1 2021 | $4,566,000 | -39.6% | 117,501 | -3.6% | 0.00% | 0.0% |
| Q4 2020 | $7,559,000 | – | 121,926 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deer IX & Co. Ltd. | 1,755,356 | $97,949,000 | 48.97% |
| Trustees of Columbia University in the City of New York | 463,298 | $28,724,000 | 38.38% |
| AJU IB Investment Co., Ltd. | 704,059 | $43,652,000 | 16.52% |
| BVF INC/IL | 2,630,658 | $163,101,000 | 6.42% |
| Redmile Group, LLC | 2,720,489 | $168,670,000 | 2.04% |
| Bain Capital Life Sciences Investors, LLC | 479,605 | $29,735,000 | 1.87% |
| Rock Springs Capital Management LP | 713,865 | $44,260,000 | 0.94% |
| SPHERA FUNDS MANAGEMENT LTD. | 147,700 | $9,157,000 | 0.81% |
| HighVista Strategies LLC | 17,117 | $1,061,000 | 0.68% |
| Logos Global Management LP | 110,920 | $6,877,000 | 0.59% |